Anti-Hu CD158d PE

*Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 2006 Jan;4 (1) :e9., URL: https://www.ncbi.nlm.nih.gov/pubmed/16366734?itool, *Yan WH, Fan LA: Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res. 2005 Mar;15 (3) :176-82., URL: https://www.ncbi.nlm.nih.gov/pubmed/15780179?itool, *LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED: HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 2005 Apr;19 (6) :662-4., URL: https://www.ncbi.nlm.nih.gov/pubmed/15670976?itool, *Rajagopalan S, Fu J, Long EO: Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol. 2001 Aug 15;167 (4) :1877-81., URL: https://www.ncbi.nlm.nih.gov/pubmed/11489965?itool, *Goodridge JP, Witt CS, Christiansen FT, Warren HS: KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol. 2003 Aug 15;171 (4) :1768-74., URL: https://www.ncbi.nlm.nih.gov/pubmed/12902476?itool